Institute of Medical Physics, University of Erlangen-Nurnberg
Erlangen, Bavaria, 91052, Germany
NCT Number: NCT01177761
The study determines the long-term effect of exercise on osteoporotic fracture risk. Since actually no controlled supervised exercise study exceeds the time frame of 4 years, knowledge concerning the long-term effect of exercise on fractures and fracture-risk factors is scarce. Within the Erlanger Fitness and Osteoporosis Study (EFOPS, an ongoing controlled exercise study with currently 16 years of supervised exercise with 45-50 osteopenic, early-postmenopausal women in exercise and sedentary control group each, the investigators therefore focus on overall-fractures, Bone Mineral Density and falls.
Looking for future studies?
Notify Me48 year and older
Female
Interventional
Not applicable
Erlangen, Bavaria, 91052, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two sessions/week, 50 weeks/year over 12 years of high intensity exercise training
Time frame: 16 year follow-up
As assessed by questionnaire and structured interview
Time frame: 16 year follow-up
As assessed by Dual-Energy X-ray Absorptiometry (DEXA)
Time frame: 16 year follow-up
As assessed by Framingham Risk Factor Calculator according to Wilson.
Time frame: 16 year follow-up
Metabolic Syndrome Z-Score Index according to Johnson
University of Erlangen-Nürnberg Medical School
Other
Effects of Exercise on Fracture Risk, Bone Mineral Density and Falls in Postmenopausal Women. The Long-term Erlangen Fitness and Prevention Study.
Acronym: EFOPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT00643331
Behavior, Bone Diseases
Melbourne, Victoria, Australia
View Trial DetailsNCT05721014
Behavior, Bone Density, Low
Huddinge, Stockholm County, Sweden
View Trial DetailsNCT00523341
Bone Diseases, Bone Diseases, Metabolic
View Trial Details